DEVELOPMENT OF AN ANALYTICAL METHOD FOR THE DOSAGE OF CANNABIDIOL AND ITS ACTIVE METABOLITE 7-HYDROXY-CANNABIDIOL ON DRIED BLOOD SPOT FOR THERAPEUTIC MONITORING OF PATIENTS WITH EPILEPSY (Q4199055)
Jump to navigation
Jump to search
Project Q4199055 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | DEVELOPMENT OF AN ANALYTICAL METHOD FOR THE DOSAGE OF CANNABIDIOL AND ITS ACTIVE METABOLITE 7-HYDROXY-CANNABIDIOL ON DRIED BLOOD SPOT FOR THERAPEUTIC MONITORING OF PATIENTS WITH EPILEPSY |
Project Q4199055 in Italy |
Statements
12,500.0 Euro
0 references
25,000.0 Euro
0 references
50.0 percent
0 references
B.S.N. - BIOLOGICAL SALES NETWORK - S.R.L.
0 references
IL PROGETTO PREVEDE LO SVILUPPO DI UN METODO CHIMICO-ANALITICO DI DOSAGGIO DEL CANNABIDIOLO E DEL 7(OH) CANNABIDIOLO FINALIZZATO ALLA COMMERCIALIZZAZIONE AI LABORATORI DI ANALISI CLINICHE DI UN KIT DIAGNOSTICO PER LA MISURAZIONE DELLA CONCENTRAZIONE DI FARMACI E DI CONSEGUENZA IL LORO MONITORAGGIO TERAPEUTICO. (Italian)
0 references
THE PROJECT INVOLVES THE DEVELOPMENT OF A CHEMICAL-ANALYTICAL METHOD OF DOSING CANNABIDIOL AND 7(OH) CANNABIDIOL AIMED AT THE MARKETING TO CLINICAL ANALYSIS LABORATORIES OF A DIAGNOSTIC KIT FOR THE MEASUREMENT OF THE CONCENTRATION OF DRUGS AND CONSEQUENTLY THEIR THERAPEUTIC MONITORING. (English)
1 February 2022
0 references
LE PROJET COMPREND LA MISE AU POINT D’UNE MÉTHODE CHIMIQUE-ANALYTIQUE DE DOSAGE DU CANNABIDIOL ET DU 7(OH) CANNABIDIOL VISANT À LA COMMERCIALISATION AUPRÈS DES LABORATOIRES D’ANALYSE CLINIQUE D’UN KIT DE DIAGNOSTIC POUR LA MESURE DE LA CONCENTRATION DES MÉDICAMENTS ET, PAR CONSÉQUENT, LEUR SURVEILLANCE THÉRAPEUTIQUE. (French)
2 February 2022
0 references
CASTELLEONE
0 references